Drugs Made In America Acquisition Corp.
DMAA· Nasdaq
DMAADrugs Made In America Acquisition Corp.
Filed Aug 14, 2026 · 10-Q · 45 days after period end · 0001213900-26-090035
| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Net Income | $1.73M | $2.29M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Drugs Made In America Acquisition Corp. · CIK 2028614 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end
